Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
International Journal of Antimicrobial Agents|May 24, 2016
Development of efflux pump inhibitors in antituberculosis therapyLele Song, Xueqiong WuThe Indian Journal of Tuberculosis|June 8, 2021
Is the tuberculosis vaccine BCG an alternative weapon for developing countries to defeat COVID-19?Wenping Gong, Xueqiong WuFrontiers in Microbiology|November 8, 2021
Differential Diagnosis of Latent Tuberculosis Infection and Active Tuberculosis: A Key to a Successful Tuberculosis Control StrategyWenping Gong, Xueqiong WuBiomed Research International|February 7, 2020
Animal Models of Tuberculosis Vaccine Research: An Important Component in the Fight against TuberculosisWenping Gong, Yan Liang, Xueqiong WuBiomed Research International|March 7, 2022
Advances in Key Drug Target Identification and New Drug Development for TuberculosisJie Mi, Wenping Gong, Xueqiong WuHuman Vaccines & Immunotherapeutics|March 31, 2018
The current status, challenges, and future developments of new tuberculosis vaccinesWenping Gong, Yan Liang, Xueqiong WuFrontiers in Microbiology|July 5, 2024
The advances in adjuvant therapy for tuberculosis with immunoregulatory compoundsJie Mi, Xueqiong Wu, Jianqin LiangInternational Reviews of Immunology|May 31, 2022
SARS-CoV-2 variants and COVID-19 vaccines: Current challenges and future strategiesWenping Gong, Seppo Parkkila, Xueqiong Wu, et al.Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|December 3, 2014
Role of calcium channels in cellular antituberculosis effects: Potential of voltage-gated calcium-channel blockers in tuberculosis therapyLele Song, Ruina Cui, Yourong Yang, et al.Frontiers in Cellular and Infection Microbiology|April 6, 2026
Research progress in PANoptosis mechanisms and their interplay with tuberculosisXue Ma, Yan Liang, Xueqiong Wu, et al.Pageof 9